MYLANTA TABLETS DOUBLE STRENGTH
MYLANTA TABLETS DOUBLE STRENGTH
Discontinued
DIN Number
02019787
Drug Class
Human
Market Date
Dec 31, 1993
Company
HC
mcneil consumer healthcare division of johnson & johnson inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02019787
AIG Number0301453009
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
A02AF02 ORDINARY SALT COMBINATIONS AND ANTIFLATULENTS
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification56:04.00
Health Canada Classification
ACTIVE INGREDIENTS (3)
ALUMINUM HYDROXIDEActive
Strength: 400 MG
Monograph: ALUMINUM HYDROXIDE
DIMETHICONEActive
Strength: 30 MG
Monograph: DIMETHICONE
MAGNESIUM HYDROXIDEActive
Strength: 400 MG
Monograph: MAGNESIUM HYDROXIDE